Export

EN
FR
Gliclazide
Essential medicine status
Section:
18. Medicines for endocrine disorders 18.5. Medicines for diabetes 18.5.2. Oral hypoglycaemic agents
ATC codes: A10BB09
Indication
Type 2 diabetes mellitus ICD11 code: 5A11
INN
Gliclazide
Medicine type
Chemical agent
List type
Core
Additional notes
glibenclamide not suitable above 60 years.
Formulations
Oral > Solid: 30 mg controlled-release ; 60 mg controlled-release ; 80 mg controlled-release
EML status history
First added in 2013 (TRS 985)
Changed in 2021 (TRS 1035)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives are medicines in the 4th level ATC chemical subgroup A10BB Sulfonylureas
Patent information
Patents have expired in most jurisdictions
Wikipedia
Gliclazide
DrugBank
Gliclazide
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended that medicines in 4th level ATC chemical subgroup, A10BB Sulfonylureas, be specified as therapeutic alternatives under the square box listing for gliclazide on the EML.